Home > Clinical Trials
Check All Search

Saved trials

Completed
NCT01611077
Efficacy and Safety of a Therapy Change From Candesartan 32 mg to Fixed Combination of Olmesartan 40 mg/Amlodipine 10 mg
88 Enrollment(s)
11 Study location(s)
Interventional (Phase IV)
Hypertension
Completed
NCT02587260
Hunting for the Off-Target Properties of Ticagrelor on Endothelial Function in Humans (HI-TECH)
54 Enrollment(s)
5 Study location(s)
Interventional (Phase IV)
Cardiovascular Diseases
Completed
NCT02478645
Dose-ranging Study of Ramosetron for the Prevention of Nausea and Vomiting After Gynecologic Laparoscopic Surgery
177 Enrollment(s)
1 Study location(s)
Interventional (Phase IV)
Postoperative Nausea and Vomiting
Unknown status
NCT02849483
Effect of Ramosetron on Bowel Motility After Gynecological Surgery
88 Enrollment(s)
1 Study location(s)
Interventional (Phase IV)
Postoperative Nausea and Vomiting
Completed
NCT01538446
Tailored Antiplatelet Therapy Versus Recommended Dose of Prasugrel
880 Enrollment(s)
2 Study location(s)
Interventional (Phase IV)
Acute Coronary Syndrome
Unknown status
NCT03016611
Chewing Ticagrelor Versus Prasugrel in ST-elevation Myocardial Infarction - A Platelet Reactivity Study
100 Enrollment(s)
1 Study location(s)
Interventional (Phase IV)
Acute Coronary Syndrome
STEMI
Completed
NCT01957540
Differential Effect of Ticagrelor Versus Prasugrel Maintenance Dose on Endothelial Function of Peripheral Vessels in Patients With Coronary Artery Disease
22 Enrollment(s)
1 Study location(s)
Interventional (Phase IV)
Coronary Artery Disease
Endothelial Function
Completed
NCT01785472
Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Asian Patients With Essential Hypertension
1,438 Enrollment(s)
50 Study location(s)
Interventional (Phase III)
Essential Hypertension